AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2012
Mar 14, 2012
31982_dirs_2012-03-14_0ef25645-4aa0-461e-9e76-8cd32963fc1e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2012-03-01
Reporting Person: Wilson Russell P (SVP, Business Development)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-03-01 | Options-right to buy | $1.28 | A | 25000 | Acquired | 2022-03-01 | Common Stock (25000) | Direct |
Footnotes
F1: Options shall vest in four equal annual installments beginning on the first anniversary of the date of grant.